Mild to moderate Alzheimer dementia with insufficient neuropathological changes-Reference-Cited by-同舟云学术

Mild to moderate Alzheimer dementia with insufficient neuropathological changes

Published:2014-04 Issue:4 Volume:75 Page:597-601
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Serrano-Pozo Alberto¹²³,Qian Jing⁴,Monsell Sarah E.⁵,Blacker Deborah¹⁶⁷,Gómez-Isla Teresa¹²,Betensky Rebecca A.¹⁷,Growdon John H.¹²,Johnson Keith A.¹²,Frosch Matthew P.¹⁸,Sperling Reisa A.¹⁹,Hyman Bradley T.¹²

Affiliation:

1. Massachusetts Alzheimer Disease Research Center; Charlestown MA

2. Department of Neurology; Massachusetts General Hospital; Boston MA

3. Department of Neurology; University of Iowa Hospitals & Clinics; Iowa city IA

4. Division of Biostatistics and Epidemiology; University of Massachusetts; Amherst MA

5. National Alzheimer's Coordinating Center and Department of Epidemiology; University of Washington; Seattle WA

6. Department of Psychiatry; Massachusetts General Hospital; Boston MA

7. Harvard School of Public Health; Boston MA

8. C. S. Kubik Laboratory for Neuropathology; Massachusetts General Hospital; Boston MA

9. Department of Neurology; Brigham and Women's Hospital; Boston MA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference20 articles.

1. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study;Rinne;Lancet Neurol,2010

2. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab;Ostrowitzki;Arch Neurol,2012

3. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association;Johnson;Alzheimers Dement,2013

4. Sperling R Salloway S Raskind M http://www.ctad.fr/07-download/Congres2012/PressRelease/Final-Sperling-CTAD-Presentation-10-29-12.pdf

5. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease;Salloway;N Engl J Med,2014

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome;Frontiers in Neurology;2024-08-14

2. Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model;Frontiers in Pharmacology;2024-08-06

3. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow;Frontiers in Pharmacology;2024-05-24

4. 2024 Alzheimer's disease facts and figures;Alzheimer's & Dementia;2024-04-30

5. Leveraging electronic health records and knowledge networks for Alzheimer’s disease prediction and sex-specific biological insights;Nature Aging;2024-02-21